Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Abbvie Inc billboard -by Poetra_ RH via Shutterstock
Is AbbVie Stock Underperforming the Dow? Barchart - Tue Feb 24, 9:29AM CST

Although AbbVie has lagged behind the Dow recently, analysts remain moderately optimistic about the stock’s prospects.

$DOWI : 49,174.50 (+0.76%)
ABBV : 228.44 (-0.45%)
PFE : 27.14 (+0.30%)
AbbVie to Present at the TD Cowen 46th Annual Health Care Conference PR Newswire - Tue Feb 24, 7:00AM CST

NORTH CHICAGO, Ill. , Feb. 24, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026. Management will participate...

ABBV : 228.44 (-0.45%)
AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States PR Newswire - Mon Feb 23, 10:00AM CST

NORTH CHICAGO, Ill. , Feb. 23, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced a new $380 million investment to build two new active pharmaceutical ingredient (API) manufacturing facilities...

ABBV : 228.44 (-0.45%)
DBX
1 Cash-Producing Stock to Target This Week and 2 We Ignore StockStory - Sun Feb 22, 10:45PM CST

1 Cash-Producing Stock to Target This Week and 2 We Ignore

VRNS : 21.71 (+2.99%)
DBX : 24.28 (-0.90%)
ABBV : 228.44 (-0.45%)
U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) PR Newswire - Fri Feb 20, 1:00AM CST

NORTH CHICAGO, Ill. , Feb. 20, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for...

ABBV : 228.44 (-0.45%)
AbbVie Declares Quarterly Dividend PR Newswire - Thu Feb 19, 8:37AM CST

NORTH CHICAGO, Ill. , Feb. 19, 2026 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per share. 

ABBV : 228.44 (-0.45%)
ABBV
1 Mega-Cap Stock on Our Watchlist and 2 We Avoid StockStory - Tue Feb 17, 10:32PM CST

1 Mega-Cap Stock on Our Watchlist and 2 We Avoid

JPM : 297.30 (-0.12%)
ORCL : 146.14 (+3.42%)
ABBV : 228.44 (-0.45%)
ABBV
The 5 Most Interesting Analyst Questions From AbbVie’s Q4 Earnings Call StockStory - Tue Feb 10, 11:35PM CST

The 5 Most Interesting Analyst Questions From AbbVie’s Q4 Earnings Call

ABBV : 228.44 (-0.45%)
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market FinancialNewsMedia - Tue Feb 10, 7:30AM CST

EQNX::TICKER_START (NASDAQ:HELP),(NYSE:JNJ),(NYSE:ABBV),(NYSE:TAK),(NYSE:AZN) EQNX::TICKER_END

HELP : 7.37 (+9.51%)
AZN : 206.61 (+0.81%)
JNJ : 246.28 (+0.71%)
HELP.NE : 9.9600 (+7.10%)
ABBV : 228.44 (-0.45%)
TAK : 18.65 (-0.80%)
ABBV
3 Market-Beating Stocks to Research Further StockStory - Sun Feb 8, 10:41PM CST

3 Market-Beating Stocks to Research Further

CCB : 78.90 (+4.30%)
BX : 116.41 (+2.37%)
ABBV : 228.44 (-0.45%)

Barchart Exclusives

This Blue-Chip Stock Just Slashed Its Dividend by 50%. Should You Run Away Now? Barchart - 49 minutes ago
LyondellBasell’s 50% dividend cut shocks income investors, but the move may signal balance-sheet defense rather than long-term weakness. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot